Does Rallies show 13F holders for KRRO?

Yes. Rallies tracks hedge fund and 13F ownership data for KRRO, including fund names, share counts, latest tracked quarter, and position changes when available.

Is KRRO research on Rallies investment advice?

No. Rallies provides research, data, and educational context for KRRO. It does not provide personalized investment advice.

KRRO (Korro Bio, Inc. Common Stock) Stock Analysis - Hedge Fund Holdings

Korro Bio, Inc. Common Stock (KRRO) is a publicly traded Healthcare sector company. As of May 19, 2026, KRRO trades at $9.54 with a market cap of $146.82M and a P/E ratio of -0.85. KRRO moved -3.31% today. Year to date, KRRO is +23.85%; over the trailing twelve months it is -34.02%. Its 52-week range spans $5.20 to $98.00. Analyst consensus is strong buy with an average price target of $20.13. Rallies surfaces KRRO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns KRRO stock?

Hedge funds tracked by Rallies that own KRRO include Orbimed Advisors. The latest tracked quarter is Sep 30, 2025. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Korro Bio, Inc. Common Stock.

KRRO Key Metrics

Key financial metrics for KRRO
Metric	Value
Price	$9.54
Market Cap	$146.82M
P/E Ratio	-0.85
EPS	$-11.67
Dividend Yield	0.00%
52-Week High	$98.00
52-Week Low	$5.20
Volume	52.20K
Avg Volume	0
Revenue (TTM)	$3.84M
Net Income	$-113.50M
Gross Margin	0.00%

Top Hedge Funds Holding KRRO

Orbimed Advisors holds 32.40K shares of KRRO, changed +0.00% as of Sep 30, 2025.

Latest KRRO News

Korro Bio Reports Over 90% SERPINA1 Editing and 95% Z-AAT Reduction with KRRO-111 — May 19, 2026
Korro Bio Raises $85M, Extends Cash Runway to H2 2028; Advances RNA Editing Programs — May 7, 2026
Korro Bio Nominates KRRO-121 Candidate, Secures $85M Private Placement — Mar 12, 2026
Korro Bio Secures $85M Oversubscribed PIPE, Extends Runway to H2 2028 — Mar 9, 2026

Recent KRRO Insider Trades

Lynx1 Capital Management LP bought 520 (~$5.51K) on Mar 31, 2026.
Yang Rick bought 207.10K (~$2.30M) on Mar 10, 2026.
SANDELL SCOTT D bought 207.10K (~$2.30M) on Mar 10, 2026.

KRRO Analyst Consensus

9 analysts cover KRRO: 0 strong buy, 8 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $20.13.

Common questions about KRRO

Who owns KRRO stock?: Hedge funds tracked by Rallies that own KRRO include Orbimed Advisors. The latest tracked quarter is Sep 30, 2025. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Korro Bio, Inc. Common Stock.
Does Rallies show 13F holders for KRRO?: Yes. Rallies tracks hedge fund and 13F ownership data for KRRO, including fund names, share counts, latest tracked quarter, and position changes when available.
Is KRRO research on Rallies investment advice?: No. Rallies provides research, data, and educational context for KRRO. It does not provide personalized investment advice.